This Weekly’s Hot Topics

  • This Thursday, April 29, training to protect MICRA. California News
  • Looking for patients willing to share their stories. COA News
  • TOMORROW! Wednesday, April 28, live webinar MPN. Industry News

We have been made aware that various payers are beginning to implement policies that place step-edits for Intravenous Iron Therapy drugs. The step-edits force patients to try and fail on older treatments before having access to newer, more effective treatments. Have you experienced this? If so, how is this affecting your practice? To read more click here and go to MOASC News.

California oncology supports Assembly Bill 32 Telehealth (AB 32). AB 32 would allow for California patients with cancer to continue receiving necessary care through telemedicine. Committee passage of AB 32 would be a big step forward in assuring patients can continue receiving care they need. Contact your Assembly Member today to encourage them to pass this bill. To read more click here and go to California News.

The FDA is holding a three-day meeting this week to review the safety and efficacy of cancer drugs approved through an accelerated pathway to determine whether the drugs have lived up to their makers’ promises. The FDA will hear from Bristol Myers Squibb, Merck and Roche, and a panel of experts will advise the agency whether to revoke any indications for Opdivo, Keytruda and Tecentriq. To read more click here and go to National News.

To read the complete California Oncology Weekly Newsletter, click on the date below.

April 27, 2021

 



No comments have been posted yet.